Author: Zaman, Mehfuz; Chandrudu, Saranya; Toth, Istvan
Title: Strategies for intranasal delivery of vaccines Cord-id: kb2wrxio Document date: 2012_7_12
ID: kb2wrxio
Snippet: The vast majority of human pathogens colonize and invade at the mucosal surfaces. Preventing infection at these sites via mucosally active vaccines is a promising and rational approach for vaccine development. However, it is only recently that the stimulation of local immunity at the mucosal surfaces has become a primary objective in addition to inducing systemic immunity. This review describes vaccine formulations designed for mucosal delivery to the nasal-associated lymphoid tissue, via intran
Document: The vast majority of human pathogens colonize and invade at the mucosal surfaces. Preventing infection at these sites via mucosally active vaccines is a promising and rational approach for vaccine development. However, it is only recently that the stimulation of local immunity at the mucosal surfaces has become a primary objective in addition to inducing systemic immunity. This review describes vaccine formulations designed for mucosal delivery to the nasal-associated lymphoid tissue, via intranasal administration. The association of antigens with mucosal adjuvants and delivery systems is emphasised.
Search related documents:
Co phrase search for related documents- active component and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date